Process for the preparation of benzo(a)quinolizidine derivatives
    1.
    发明授权
    Process for the preparation of benzo(a)quinolizidine derivatives 失效
    苯并(a)喹嗪衍生物的制备方法

    公开(公告)号:US4102886A

    公开(公告)日:1978-07-25

    申请号:US624470

    申请日:1975-10-21

    CPC分类号: C07D491/14 C07D455/06

    摘要: A process for the preparation of a compound of the formula I or a salt thereof ##STR1## wherein R.sup.1 and R.sup.2 each represent hydrogen or a C.sub.1-4 alkoxy group, or together form a methylenedioxy group;R.sup.3, r.sup.4, r.sup.5 and R.sup.6 are the same or different and are hydrogen or a group of the formula --CH.sub.2 --(CH.sub.2).sub.n --R.sup.7 with the proviso that at least one of the members R.sup.3, R.sup.4, R.sup.5 and R.sup.6 is other than hydrogen; R.sup.7 is carboxyl or a carboxylic acid derivative group;N = 0.1 or 2 which comprises reacting a compound of the formula II ##STR2## with an organic secondary amine and reacting the N-amine of the formula III ##STR3## thus obtained wherein R.sup.8 and R.sup.9 each represent a C.sub.1-5 alkyl group, or together with the adjacent nitrogen atom form a 5- or 6-membered heterocyclic ring which can contain a further heteroatom, with a compound of the formula IVch.sub.2 .dbd. ch -- (ch.sub.2).sub.n -- R.sup.10 (IV)wherein R.sup.10 is a cyano or alkoxycarbonyl group.

    摘要翻译: 一种制备式I化合物或其盐的方法,其中R 1和R 2各自代表氢或C 1-4烷氧基,或一起形成亚甲二氧基; R 3,R 4,R 5和R 6相同或不同,为氢或式-CH 2 - (CH 2)n -R 7的基团,条件是至少有一个R 3,R 4,R 5和R 6不是 氢; R7是羧基或羧酸衍生物基团; N = 0.1或2,其包含用有机仲胺反应式II化合物,并使由此得到的式III的N-胺反应,其中R 8和R 9各自表示C 1-5烷基, 或者与相邻的氮原子一起形成可以含有另外的杂原子的5或6元杂环与式IV的化合物CH2 = CH-(CH2)n-R10(IV),其中R10是氰基或 烷氧基羰基。

    Benzo(a)quinolizidine derivatives
    2.
    发明授权
    Benzo(a)quinolizidine derivatives 失效
    苯并(a)喹嗪啶衍生物

    公开(公告)号:US4342871A

    公开(公告)日:1982-08-03

    申请号:US744608

    申请日:1976-11-24

    CPC分类号: C07D491/14 C07D455/06

    摘要: An antiphlogistic compound of the formula (I) ##STR1## or a pharmaceutically effective salt thereof wherein R.sup.1 and R.sup.2 are hydrogen or C.sub.1-4 alkoxy or together form a methylenedioxy group;R.sup.3, R.sup.4, R.sup.5, and R.sup.6 are hydrogen or a group of the formula --CH.sub.2 --(CH.sub.2).sub.n -R.sup.7 with the proviso that at least one of R.sup.3, R.sup.4, R.sup.5 and R.sup.6 is other than hydrogen;R.sup.7 is a carboxylic group or a carboxylic acid derivative group; n=0, 1 or 2, provided that if R.sup.3, R.sup.4 and R.sup.5 are hydrogen and R.sup.7 in the group R.sup.6 is cyano or alkoxycarbonyl, and n=1, then R.sup.1 and R.sup.2 are hydrogen, C.sub.2-4 alkoxy, or together form a methylenedioxy group.

    摘要翻译: 式(I)的消炎化合物(I)或其药学上有效的盐,其中R 1和R 2是氢或C 1-4烷氧基或一起形成亚甲二氧基; R3,R4,R5和R6是氢或式-CH2-(CH2)n-R7的基团,条件是R3,R4,R5和R6中的至少一个不是氢; R7是羧基或羧酸衍生物基团; n = 0,1或2,条件是如果R3,R4和R5是氢,R6中的R7是氰基或烷氧基羰基,n = 1,则R1和R2是氢,C2-4烷氧基或一起形成 亚甲二氧基。